Anxiety and Depression: Your Gut May Be Controlling Your Mood More Than Your Brain

What if some of the bacteria living in your gut were influencing your anxiety, mood, and even the quality of your sleep? A massive scientific analysis has revealed surprising results that could change how we view mental health.

For a long time, anxiety and depression were believed to be problems exclusively related to the brain. Today, however, scientists know that there is constant communication between the brain and the gut.

This connection, known as the gut-brain axis, has sparked enormous interest because trillions of bacteria that naturally live in our digestive system seem to influence emotions, behavior, sleep, and even how we cope with stress.

With the global increase in anxiety and depression disorders, researchers are investigating whether modifying the gut microbiota through probiotics can help improve mental health.

Probiotics are live microorganisms that, when consumed in adequate amounts, can bring health benefits. Prebiotics are substances that serve as food for these beneficial bacteria, while synbiotics combine both.

Examples of Prebiotic Foods

In recent years, several studies have suggested that these interventions could reduce negative emotional symptoms, but the results have not always been consistent. Some research has found significant benefits, while others have observed small or nonexistent effects.

Faced with these discrepancies, an international team decided to gather all available evidence to try to answer the question more reliably.

To do this, the researchers conducted a large systematic review with meta-analysis, considered one of the most robust ways to evaluate scientific evidence. They searched three of the world's largest medical databases for randomized clinical trials, which are studies in which participants are randomly assigned to treatment groups and comparison groups.

The search included research published up to October 2023, with an additional update in March 2025. The selected studies involved people diagnosed with anxiety or depression, as well as healthy individuals or those with chronic diseases who presented relevant emotional symptoms.

After a rigorous selection process, scientists gathered data from 72 clinical studies involving more than six thousand participants. In some studies, participants received probiotics; in others, prebiotics or synbiotics. These groups were compared to people who received a placebo, a substance with no therapeutic effect.

The researchers then analyzed the results using statistical methods capable of combining the data from all studies and calculating a more reliable average effect. They also investigated whether factors such as age, health condition, duration of treatment, and type of probiotic could influence the results.

The findings were quite promising. In general, people who received probiotics, prebiotics, or synbiotics showed a significant reduction in symptoms of anxiety and depression when compared to the placebo groups. Furthermore, probiotics also demonstrated improved sleep quality.

However, the benefits were not the same for everyone. The effects varied according to the participants' profile, the duration of use, and the specific type of microorganism used. This suggests that some formulations may be more effective than others and that certain groups of people may respond better to treatment.

Researchers believe these effects may occur because gut bacteria participate in the production of chemicals important to the brain, including serotonin, dopamine, and gamma-aminobutyric acid, neurotransmitters directly involved in regulating mood and anxiety.

Furthermore, a healthy microbiota helps control inflammatory processes in the body. Since elevated levels of inflammation have been associated with various psychiatric disorders, improving gut health may indirectly benefit mental health.

Despite the encouraging results, the authors caution that probiotics cannot yet be considered a cure for anxiety or depression. Many of the included studies presented important methodological differences, used distinct bacterial strains, and followed participants for relatively short periods. Therefore, larger and more rigorous studies are needed to confirm the observed benefits and identify which microorganisms work best for each situation.

However, the research reinforces an idea increasingly accepted by modern science: the brain does not function in isolation. The gut, often called the "second brain," may play a much more important role in emotional health than we imagined.

Although probiotics do not replace traditional medical or psychological treatments, they emerge as a promising complementary strategy to help improve mood, reduce anxiety, and promote healthier sleep.

READ MORE:

The efficacy of probiotics, prebiotics, and synbiotics on anxiety, depression, and sleep: a systematic review and meta-analysis of randomized controlled trials Jialin Zhang, Linqing Zhu, Qing Meng, Zuxing Wang and Hongru Zhu

BMC Psychiatry. Volume 25, article number 1199 (2025)

DOI: 10.1186/s12888-025-07644-z

Abstract: 

With the growing recognition of the limitations associated with conventional treatments for anxiety and depression, there has been increasing interest in alternative and adjunct therapies, particularly probiotics, prebiotics, and synbiotics. However, current research results regarding their efficacy in treating anxiety, depression, and sleep have been inconsistent. A systematic literature search for randomized controlled trials (RCTs) was conducted in PubMed, Web of Science, and Embase from inception to October 2023, updated in March 2025. The included studies involved individuals with anxiety and depression disorders, or chronic disease patients/healthy populations presenting with depressive or anxiety symptoms. Two researchers independently screened and extracted data. The Cochrane risk of bias tool was used to evaluate the quality of the included studies. Data synthesis and subgroup analyses were performed in Review Manager 5.3 and Stata 15.0 software. The anxiety, depression, and sleep scores were calculated by the standard mean difference (SMD) and 95% confidence intervals (CIs). A total of 72 RCTs were included (3,319 intervention and 2,778 control participants). Among these, researchers examined depression in 63 studies (2,880 and 2,493 participants) and anxiety in 49 studies (2,124 and 1,788 participants) using probiotics/prebiotics/synbiotics interventions, while 12 studies (411 and 378 participants) examined sleep using probiotic interventions. The meta-analysis demonstrated significant reductions compared to placebo in depression (SMD = − 0.53, 95% CI: −0.67 to − 0.39, Z = 7.33, P < 0.001) and anxiety (SMD = − 0.44, 95% CI: −0.59 to − 0.28, P < 0.001). Additionally, probiotics were shown to improve sleep quality (SMD = − 0.39, 95% CI: −0.53 to − 0.25, P < 0.001). Subgroup analyses indicated that both probiotics, prebiotics, and synbiotics independently alleviated anxiety and depression. The impact of probiotics varied by population, intervention duration, and probiotic types. These findings suggest that probiotics, prebiotics, and synbiotics offer promising adjunctive treatments for anxiety, depression, and sleep disturbances. However, given the high heterogeneity and limited methodological quality of the included studies, further large-scale and high-quality RCTs with long-term follow-up are needed to further validate these outcomes. The protocol was registered on PROSPERO (Registration number: CRD42024563862).